Vertex Pharmaceuticals Inc. (VRTX) Up on Positive Drug Trials
June 25, 2014 at 09:29 AM EDT
Shares of Cambridge, Massachusetts-based Vertex Pharmaceuticals (VRTX) were up sharply on Tuesday, amid a broadly lower market on Wall Street. Vertex’s stock was up 40.41%, rising $26.92 to close at $93.53 per share, on volume of 25,236,837 shares. The company announced positive results for a drug it has formulated in treating cystic fibrosis. The successful Read the full article... Read the rest of Vertex Pharmaceuticals Inc. (VRTX) Up on Positive Drug Trials at InvestorGuide.com .